The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

Abstract Background Metastatic breast cancer (MBC) prognosis is variable, depending on several clinical and biological factors. A better prediction of a patient’s outcome could allow for a more accurate choice of treatments. The role of serum biomarkers in predicting outcome remains unclear in this...

Full description

Bibliographic Details
Main Authors: Amélie Darlix, Christophe Hirtz, Simon Thezenas, Aleksandra Maceski, Audrey Gabelle, Evelyne Lopez-Crapez, Hélène De Forges, Nelly Firmin, Séverine Guiu, William Jacot, Sylvain Lehmann
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Cancer
Subjects:
Tau protein
Breast cancer
Brain metastases
Tumor markers
Predictive factors
Prognostic factors
Online Access:http://link.springer.com/article/10.1186/s12885-019-5287-z

Internet

http://link.springer.com/article/10.1186/s12885-019-5287-z

Similar Items